PURPOSE: Preimplantation genetic testing for monogenic disorders (PGT-M) allows early diagnosis in embryos conceived in vitro. PGT-M helps to prevent known genetic disorders in affected families and ensures that pathogenic variants in the male or female partner are not passed on to offspring. The trend in genetic testing of embryos is to provide a comprehensive platform that enables robust and reliable testing for the causal pathogenic variant(s), as well as chromosomal abnormalities that commonly occur in embryos. In this study, we describe PGT protocol that allows direct mutation testing, haplotyping, and aneuploidy screening. METHODS: Described PGT protocol called OneGene PGT allows direct mutation testing, haplotyping, and aneuploidy screening using next-generation sequencing (NGS). Whole genome amplification product is combined with multiplex PCR used for SNP enrichment. Dedicated bioinformatic tool enables mapping, genotype calling, and haplotyping of informative SNP markers. A commercial software was used for aneuploidy calling. RESULTS: OneGenePGT has been implemented for seven of the most common monogenic disorders, representing approximately 30% of all PGT-M indications at our IVF centre. The technique has been thoroughly validated, focusing on direct pathogenic variant testing, haplotype identification, and chromosome abnormality detection. Validation results show full concordance with Sanger sequencing and karyomapping, which were used as reference methods. CONCLUSION: OneGene PGT is a comprehensive, robust, and cost-effective method that can be established for any gene of interest. The technique is particularly suitable for common monogenic diseases, which can be performed based on a universal laboratory protocol without the need for set-up or pre-testing.

REPROMEDA Studentska 812 6 625 00 Brno Czech Republic

See more in PubMed

Lee I, Alur-Gupta S, Gallop R, Dokras A. Utilization of preimplantation genetic testing for monogenic disorders. Fertil Steril. 2020;114(4):854–860. doi: 10.1016/j.fertnstert.2020.05.045. PubMed DOI

van Montfoort A, Carvalho F, Coonen E, Kokkali G, Moutou C, et al. ESHRE PGT Consortium data collection XIX–XX: PGT analyses from 2016 to 2017†. Hum Reprod Open. 2021;3:hoab024. doi: 10.1093/hropen/hoab024. PubMed DOI PMC

Forman EJ, Ferry KM, Gueye N-A, Smith RD, Stevens J, Scott RT. Trophectoderm biopsy for single-gene disorder preimplantation genetic diagnosis (PGD) is significantly more reliable than day 3 blastomere biopsy. Fertil Steril. 2011;96(3):S222. doi: 10.1016/j.fertnstert.2011.07.853. DOI

Fiorentino F, Biricik A, Nuccitelli A, De Palma R, Kahraman S, et al. Rapid protocol for pre-conception genetic diagnosis of single gene mutations by first polar body analysis: a possible solution for the Italian patients. Prenat Diagn. 2008;28(1):62–64. doi: 10.1002/pd.1905. PubMed DOI

Tuffs A. Germany allows restricted access to preimplantation genetic testing. BMJ. 2011;343:d4425. doi: 10.1136/bmj.d4425. PubMed DOI

Gutiérrez-Mateo C, Sánchez-García JF, Fischer J, Tormasi S, Cohen J, et al. Preimplantation genetic diagnosis of single-gene disorders: experience with more than 200 cycles conducted by a reference laboratory in the United States. Fertil Steril. 2009;92(5):1544–1556. doi: 10.1016/j.fertnstert.2008.08.111. PubMed DOI

Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47(10):651–658. doi: 10.1136/jmg.2009.069971. PubMed DOI

Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med. 2014;16(11):838–845. doi: 10.1038/gim.2014.45. PubMed DOI PMC

Renwick P, Gonzalez J, Hewitson H. Evaluation and implementation of onepgt for monogenic conditions. Reprod Biomed Online. 2019;39:e26–27. doi: 10.1016/j.rbmo.2019.04.054. DOI

De Witte L, Raman L, Baetens M, De Koker A, Callewaert N, et al. GENType: all-in-one preimplantation genetic testing by pedigree haplotyping and copy number profiling suitable for third-party reproduction. Hum Reprod. 2022;37(7):1678–1691. doi: 10.1093/humrep/deac088. PubMed DOI

Masset H, Ding J, Dimitriadou E, Ardeshirdavani A, Debrock S, et al. Single-cell genome-wide concurrent haplotyping and copy-number profiling through genotyping-by-sequencing. Nucleic Acids Res. 2022;50(11):e63. doi: 10.1093/nar/gkac134. PubMed DOI PMC

Xie P, Hu X, Kong L, Mao Y, Cheng D, et al. A novel multifunctional haplotyping-based preimplantation genetic testing for different genetic conditions. Hum Reprod. 2022;37(11):2546–2559. doi: 10.1093/humrep/deac190. PubMed DOI

Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2(4):280–291. doi: 10.1038/35066065. PubMed DOI

Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray–based comprehensive chromosome screening in infertile patients. Fertil Steril. 2011;96(3):638–640. doi: 10.1016/j.fertnstert.2011.06.049. PubMed DOI

Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv, 2013; 10.48550/arXiv.1303.3997.

Lai Z, Markovets A, Ahdesmaki M, Chapman B, Hofmann O, et al. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res. 2016;44(11):e108. doi: 10.1093/nar/gkw227. PubMed DOI PMC

ESHRE PGT-M Working Group. Carvalho F, Moutou C, Dimitriadou E, Dreesen J, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders†. Hum Reprod Open. 2020;2020(3):hoaa018. doi: 10.1093/hropen/hoaa018. PubMed DOI PMC

Coonen E, van Montfoort A, Carvalho F, Kokkali G, Moutou C, et al. ESHRE PGT Consortium data collection XVI–XVIII: cycles from 2013 to 2015†. Hum Reprod Open. 2020;2020(4):hoaa043. doi: 10.1093/hropen/hoaa043. PubMed DOI PMC

Lazarin GA, Haque IS. Expanded carrier screening: a review of early implementation and literature. Semin Perinatol. 2016;40(1):29–34. doi: 10.1053/j.semperi.2015.11.005. PubMed DOI

Capalbo A, Valero RA, Jimenez-Almazan J, Pardo PM, Fabiani M, et al. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: translational research genomic data from 14,125 exomes. PLoS Genet. 2019;15(10):e1008409. doi: 10.1371/journal.pgen.1008409. PubMed DOI PMC

Biezuner T, Raz O, Amir S, Milo L, Adar R, et al. Comparison of seven single cell whole genome amplification commercial kits using targeted sequencing. Sci Rep. 2021;11(1):17171. doi: 10.1038/s41598-021-96045-9. PubMed DOI PMC

Huang L, Ma F, Chapman A, Lu S, Xie XS. Single-cell whole-genome amplification and sequencing: methodology and applications. Annu Rev Genomics Hum Genet. 2016;16(1):79–102. doi: 10.1146/annurev-genom-090413-025352. PubMed DOI

de Bourcy CFA, De Vlaminck I, Kanbar JN, Wang J, Gawad C, Quake SR. A quantitative comparison of single-cell whole genome amplification methods. PLoS ONE. 2014;9(8):e105585. doi: 10.1371/journal.pone.0105585. PubMed DOI PMC

Chen CK, Yu HT, Soong YK, Lee CL. New perspectives on preimplantation genetic diagnosis and preimplantation genetic screening. Taiwan J Obstet Gynecol. 2014;53(2):146–150. doi: 10.1016/j.tjog.2014.04.004. PubMed DOI

Volozonoka L, Perminov D, Korņejeva L, Alkšere B, Novikova N, et al. Performance comparison of two whole genome amplification techniques in frame of multifactor preimplantation genetic testing. J Assist Reprod Genet. 2018;35(8):1457–1472. doi: 10.1007/s10815-018-1187-4. PubMed DOI PMC

Unsal E, Aktuna S, Aydin M, Ozer L, Baltacı V. Improved IVF success of combined PGT-M and PGT-A applications. Reprod Biomed Online. 2019;39:e69–70. doi: 10.1016/j.rbmo.2019.04.122. DOI

Magli MC, Gianaroli L, Ferraretti AP, Lappi M, Ruberti A, Farfalli V. Embryo morphology and development are dependent on the chromosomal complement. Fertil Steril. 2007;87(3):534–541. doi: 10.1016/j.fertnstert.2006.07.1512. PubMed DOI

Chen S, Yin X, Zhang S, Xia J, Liu P, et al. Comprehensive preimplantation genetic testing by massively parallel sequencing. Hum Reprod. 2021;36(1):236–247. PubMed

Kemper JM, Vollenhoven BJ, Talmor AJ. Preimplantation genetic testing for aneuploidy: a review. Obstet Gynecol Surv. 2019;74(12):727–737. doi: 10.1097/OGX.0000000000000737. PubMed DOI

Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, et al. Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structure. J Assist Reprod Genet. 2014;31(11):1501–1509. doi: 10.1007/s10815-014-0333-x. PubMed DOI PMC

Schaeffer E, Porchia L, López-Luna A, Hernández-Melchor D, López-Bayghen E. Aneuploidy rates inversely correlate with implantation during in vitro fertilization procedures: In Favor of PGT. Mod Med Genet Genomics. 2018; IntechOpen: London, UK, 2018; pp. 1–19

Jia CW, Wang L, Lan YL, Song R, Zhou LY, et al. Aneuploidy in early miscarriage and its related factors. Chin Med J (Engl) 2015;128(20):2772–2776. doi: 10.4103/0366-6999.167352. PubMed DOI PMC

Yang Z, Liu J, Collins GS, Salem SA, Liu X, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet. 2012;5(1):24. doi: 10.1186/1755-8166-5-24. PubMed DOI PMC

Scott RT, Ferry K, Su J, Tao X, Scott K, Treff NR. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril. 2012;97(4):870–875. doi: 10.1016/j.fertnstert.2012.01.104. PubMed DOI

Harton GL, Munné S, Surrey M, Grifo J, Kaplan B, et al. Diminished effect of maternal age on implantation after preimplantation genetic diagnosis with array comparative genomic hybridization. Fertil Steril. 2013;100(6):1695–1703. doi: 10.1016/j.fertnstert.2013.07.2002. PubMed DOI

Haddad G, Deng M, Wang CT, Witz C, Williams D, et al. Assessment of aneuploidy formation in human blastocysts resulting from donated eggs and the necessity of the embryos for aneuploidy screening. J Assist Reprod Genet. 2015;32(6):999–1006. doi: 10.1007/s10815-015-0492-4. PubMed DOI PMC

Sills ES, Li X, Frederick JL, Khoury CD, Potter DA. Determining parental origin of embryo aneuploidy: analysis of genetic error observed in 305 embryos derived from anonymous donor oocyte IVF cycles. Mol Cytogenet. 2014;7:68. doi: 10.1186/s13039-014-0068-5. PubMed DOI PMC

Popovic M, Dhaenens L, Boel A, Menten B, Heindryckx B. Chromosomal mosaicism in human blastocysts: the ultimate diagnostic dilemma. Hum Reprod Update. 2020;26(3):313–334. doi: 10.1093/humupd/dmz050. PubMed DOI

Viotti M, Victor AR, Barnes FL, Zouves CG, Besser AG, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021;115(5):1212–1224. doi: 10.1016/j.fertnstert.2020.11.041. PubMed DOI